BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38492433)

  • 21. [Hepatitis C in prisons : Treatment and barriers to the elimination goals of the United Nations].
    Dichtl A; Jamin D; Stöver H; Grabski M; Knorr B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2024 Jan; 67(1):36-44. PubMed ID: 38155308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel.
    Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C;
    Int J Drug Policy; 2021 Dec; 98():103379. PubMed ID: 34311138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
    Skipper C; Guy JM; Parkes J; Roderick P; Rosenberg WM
    Gut; 2003 Oct; 52(10):1500-4. PubMed ID: 12970145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection, stratification and treatment of hepatitis C-positive prisoners in the United Kingdom prison estate: Development of a pathway of care to facilitate the elimination of hepatitis C in a London prison.
    Connoley D; Francis-Graham S; Storer M; Ekeke N; Smith C; Macdonald D; Rosenberg W
    J Viral Hepat; 2020 Oct; 27(10):987-995. PubMed ID: 32449969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting.
    Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C;
    Int J Drug Policy; 2020 Mar; 77():102693. PubMed ID: 32045828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus infection in Irish drug users and prisoners - a scoping review.
    Crowley D; Murtagh R; Cullen W; Lambert JS; McHugh T; Van Hout MC
    BMC Infect Dis; 2019 Aug; 19(1):702. PubMed ID: 31395032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland.
    Stone J; Martin NK; Hickman M; Hutchinson SJ; Aspinall E; Taylor A; Munro A; Dunleavy K; Peters E; Bramley P; Hayes PC; Goldberg DJ; Vickerman P
    Addiction; 2017 Jul; 112(7):1302-1314. PubMed ID: 28257600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada.
    Godin A; Kronfli N; Cox J; Alary M; Maheu-Giroux M
    Int J Drug Policy; 2021 Feb; 88():102738. PubMed ID: 32278651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of HCV in prisons in Wales, UK and the impact of moving to opt-out HCV testing.
    Perrett SE; Plimmer A; Shankar AG; Craine N
    J Public Health (Oxf); 2020 May; 42(2):423-428. PubMed ID: 32090269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "That was quick, simple, and easy": Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison.
    Lafferty L; Cochrane A; Sheehan Y; Treloar C; Grebely J; Lloyd AR
    Int J Drug Policy; 2022 Jan; 99():103456. PubMed ID: 34560624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 'I just keep thinking I haven't got it because I'm not yellow': a qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners.
    Khaw FM; Stobbart L; Murtagh MJ
    BMC Public Health; 2007 Jun; 7():98. PubMed ID: 17555573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus screening and treatment in Irish prisons from nurse managers' perspectives - a qualitative exploration.
    Crowley D; Van Hout MC; Murphy C; Kelly E; Lambert JS; Cullen W
    BMC Nurs; 2019; 18():23. PubMed ID: 31210751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison.
    Lafferty L; Rance J; Grebely J; Lloyd AR; Dore GJ; Treloar C;
    J Viral Hepat; 2018 Dec; 25(12):1526-1532. PubMed ID: 30141261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London.
    Aisyah DN; Shallcross L; Hayward A; Aldridge RW; Hemming S; Yates S; Ferenando G; Possas L; Garber E; Watson JM; Geretti AM; McHugh TD; Lipman M; Story A
    J Viral Hepat; 2018 Nov; 25(11):1260-1269. PubMed ID: 29851232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care.
    Papaluca T; McDonald L; Craigie A; Gibson A; Desmond P; Wong D; Winter R; Scott N; Howell J; Doyle J; Pedrana A; Lloyd A; Stoove M; Hellard M; Iser D; Thompson A
    J Hepatol; 2019 May; 70(5):839-846. PubMed ID: 30654067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contemporary women prisoners health experiences, unique prison health care needs and health care outcomes in sub Saharan Africa: a scoping review of extant literature.
    Van Hout MC; Mhlanga-Gunda R
    BMC Int Health Hum Rights; 2018 Aug; 18(1):31. PubMed ID: 30081894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimates of Hepatitis C Seroprevalence and Viremia in State Prison Populations in the United States.
    Spaulding AC; Kennedy SS; Osei J; Sidibeh E; Batina IV; Chhatwal J; Akiyama MJ; Strick LB
    J Infect Dis; 2023 Sep; 228(Suppl 3):S160-S167. PubMed ID: 37703336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries.
    Maticic M; Pirnat Z; Leicht A; Zimmermann R; Windelinck T; Jauffret-Roustide M; Duffell E; Tammi T; Schatz E
    Harm Reduct J; 2020 Nov; 17(1):89. PubMed ID: 33213481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting.
    Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C
    Addiction; 2021 May; 116(5):1162-1171. PubMed ID: 33006784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C in Israeli prisons: status report.
    Michaeli N; Litvin A; Davidovitch N
    Harm Reduct J; 2020 Oct; 17(1):79. PubMed ID: 33076926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.